Christopher J Kane
University of California, San Diego
H-index: 83
North America-United States
Top articles of Christopher J Kane
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Post radical prostatectomy (RP) PSA outcomes following 6 versus 18 months of perioperative androgen receptor signaling inhibitors (ARSI) in men with localized high-risk … | Rana R McKay Wanling Xie Xiaoyu Yang Andres Acosta Dana E Rathkopf | 2024/2/1 | |
MP31-16 GERMLINE GENETIC TESTING FOR PROSTATE CANCER: ORDERING TRENDS IN THE ERA OF EXPANDED HEREDITARY CANCER SCREENING RECOMMENDATIONS | The Journal of Urology | Jacob L Roberts Luke L Wang Brent Rose Tyler Siebert Lisa Madlensky | 2024/5 |
A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 … | Rana R McKay Lin Liu Minya Pu Arlene Araneta Luke Wang | 2024/2/1 | |
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before … | Prostate Cancer and Prostatic Diseases | Mahdi Mottaghi Lin Gu Sriram Deivasigamani Eric S Adams Joshua Parrish | 2024/4/11 |
Improved correction of B0 inhomogeneity-induced distortions in diffusion-weighted images of the prostate | medRxiv | Christopher C Conlin Aditya Bagrodia Tristan Barrett Madison T Baxter Deondre D Do | 2024 |
Blockade of Wnt5A/ROR1 signaling as cancer stem cell targeting therapy for metastatic prostate cancer | Cancer Research | Christina AM Jamieson Jamillah Murtadha Christopher S Oh Michelle T Muldong Niloofar Etemadfard | 2024/3/22 |
PD05-08 ADDRESSING RACIAL DISPARITIES IN PROSTATE CANCER PATHOLOGY PREDICTION MODELS: EXTERNAL VALIDATION AND COMPARISON OF FOUR MODELS OF PATHOLOGICAL OUTCOME PREDICTION … | The Journal of Urology | Mahdi Mottaghi Lin Gu Sriram Deivasigamani Eric S Adams Joshua Parrish | 2024/5 |
Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable … | Cancer | Rana R McKay Wanling Xie Xiaoyu Yang Andres Acosta Dana Rathkopf | 2024 |
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era | Urologic Oncology: Seminars and Original Investigations | Sanjay Das Michael Luu Martha Terris Zachary Klaassen Christopher J Kane | 2024/3/15 |
MP58-18 DOES EQUAL ACCESS MEAN EQUAL ACCESS TO SECONDARY TREATMENTS AFTER BIOCHEMICAL RECURRENCE (BCR) FOLLOWING RADICAL PROSTATECTOMY (RP) | The Journal of Urology | Anael Rizzo Shakiba Eslamimehr Christopher L Amling William J Aronson Christopher Kane | 2024/5 |
Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH | Cancer medicine | Lourdes Guerrios‐Rivera Jessica L Janes Amanda M De Hoedt Zachary Klaassen Martha K Terris | 2024/2 |
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic … | Prostate Cancer and Prostatic Diseases | Zachary Klaassen Lauren Howard Christopher JD Wallis Jessica L Janes Amanda De Hoedt | 2023/3 |
Pre-clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer | Cancer Research | Christina AM Jamieson Jamillah Murtadha Christopher S Oh Michelle Muldong Evodie Koutouan | 2023/4/4 |
Robotic Bladder Autotransplantation: Preclinical Studies in Preparation for First-in-human Bladder Transplant EDITORIAL COMMENT | The Journal of Urology | Nima Nassiri Giovanni Cacciamani Inderbir S Gill | 2023/10 |
Automated patient-level prostate cancer detection with quantitative diffusion magnetic resonance imaging | European Urology Open Science | Allison Y Zhong Leonardino A Digma Troy Hussain Christine H Feng Christopher C Conlin | 2023/1/1 |
MP67-09 RELATIONSHIP BETWEEN SKIN CANCER AND AGGRESSIVE PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE | The Journal of Urology | John m Masterson Jaruda Ithisuphalap Durham NC Emilie J Fowler Christopher L Amling | 2023/4 |
Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort | Cancer Epidemiology, Biomarkers & Prevention | Andrei Sergeyev Lin Gu Amanda M De Hoedt Christopher L Amling William J Aronson | 2023/9/1 |
PD04-10 PRE-CLINICAL STUDIES TO ADVANCE ZILOVERTAMAB-BASED ANTI-ROR1 DUAL SPECIFICITY CAR T-CELL THERAPY FOR METASTATIC PROSTATE CANCER. | The Journal of Urology | Christina Jamieson Jamillah Murtadha Christopher S Oh Michelle Muldong Evodie Koutouan | 2023/4 |
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement | Prostate Cancer and Prostatic Diseases | Juan Javier-DesLoges Marc A Dall’Era Wayne Brisbane Karim Chamie Samuel L Washington III | 2023/8/8 |
Prognostic value of the intermediate-risk feature in men with favorable intermediate-risk prostate cancer: implications for active surveillance | European Urology Open Science | Michael V Sherer Austin J Leonard Tyler J Nelson P Travis Courtney Kripa Guram | 2023/4/1 |
